CORRECTED: BioTrove Purchases Patent Portfolio from Genencor | GenomeWeb

CORRECTION: A September 29, 2003 GenomeWeb News article stated that BioTrove had licensed from Genencor International a portfolio of patents and patents and patent filings related to nanofluidic through-hole array technology. In fact, BioTrove purchased the portfolio of patents from Genencor.  GenomeWeb regrets the error.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.